From Bench to Bedside: Evaluation of AHCC Supplementation to Modulate the Host Immunity to Clear High-Risk Human Papillomavirus Infections

From Bench to Bedside: Evaluation of AHCC Supplementation to Modulate the Host Immunity to Clear High-Risk Human Papillomavirus Infections

Objective: There is currently no effective medicine or supplement for clearance of high risk- human papillomavirus (HR-HPV) infections. We have taken a systematic approach evaluating the potential use of AHCC supplementation to support clearance of HR-HPV infections. The primary objective of this re...

Full description

Bibliographic Details
Main Authors: Judith A. Smith, Lata Mathew, Anjali Gaikwad, Barbara Rech, Maryam N. Burney, Jonathan P. Faro, Joseph A. Lucci, Yu Bai, Randall J. Olsen, Teresa T. Byrd
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-03-01
Series:Frontiers in Oncology
Subjects:
AHCC
HPV
prevention
nutritional supplementation
cervical cancer
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00173/full

Similar Items

Similar Items